The anti-interleukin agent romilkimab showed significant benefits on skin fibrosis among patients with systemic sclerosis in a phase II trial, researchers reported. At week 24, the least squares mean ...
Patients with SSc were linked to an increased risk for hematological malignancies, specifically B-cell malignancies.
Telitacicept, a dual inhibitor of the cytokines B-lymphocyte stimulator and a proliferation-inducing ligand, showed efficacy ...
Refractory dry eye in patients with systemic comorbidities can be challenging to manage because the underlying condition or ...
Nutritional issues such as ARFID are highly prevalent among patients with SSc and can lead to poor outcomes and other ...
SPRINGFIELD, Ohio — Tyeesha Ferguson fears her 28-year-old son will kill or be killed. "That's what I'm trying to avoid," said Ferguson, who still calls Quincy Jackson III her baby. She remembers a ...
Objectives The European Alliance of Associations for Rheumatology (EULAR) recommendations for the management of systemic lupus erythematosus (SLE) and lupus nephritis provide important guidance for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback